$59.70 +0.24 (%) Merck & Co Inc - NYSE

May. 28, 2015 | 04:00 PM

Partner Headlines

  1. Merck got EU's CHMP

    IBD | May. 22, 2015 | 18:22PM EST
  2. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  3. Puma Crashes, Roche Rises On Cancer Data News

    IBD | May. 14, 2015 | 12:59PM EST
  4. Intrexon

    IBD | May. 11, 2015 | 18:46PM EST
  5. MERCK

    IBD | May. 11, 2015 | 18:46PM EST
  6. Merck's Stock Price, Dividend Yield Beating S&P 500

    IBD | May. 6, 2015 | 18:13PM EST
  7. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus | May. 4, 2015 | 19:24PM EST
  8. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus | May. 2, 2015 | 16:04PM EST
  9. Big Pharma Beats Wall St.

    IBD | Apr. 28, 2015 | 19:11PM EST
  10. Merck Jumps, United Therapeutics Drops On Q1 Earnings

    IBD | Apr. 28, 2015 | 18:50PM EST
  11. Stocks Recover Off Lows, End Mixed; Twitter Crashes

    IBD | Apr. 28, 2015 | 16:16PM EST
  12. Stocks Recover After Volatile Start; Merck Props Up Dow

    IBD | Apr. 28, 2015 | 14:47PM EST
  13. Merck Up On Q1, Januvia Report; Bristol, Pfizer Mixed

    IBD | Apr. 28, 2015 | 12:47PM EST
  14. Stocks Recover From Iran News, Weak Consumer Confidence

    IBD | Apr. 28, 2015 | 12:04PM EST
  15. Stock Futures Mixed, Nasdaq Up; Apple, Vasco, Merck Rising

    IBD | Apr. 28, 2015 | 09:02AM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Apr. 28, 2015 | 08:21AM EST
  17. Merck Beats Q1 Estimates, Shares Rise

    Benzinga | Apr. 28, 2015 | 08:08AM EST
  18. After Hours: Merck Perks; Pot Biotech Is A Downer

    IBD | Apr. 27, 2015 | 20:00PM EST
  19. MERCK

    IBD | Apr. 27, 2015 | 18:45PM EST
  20. 4 Drug Giants Reporting Earnings This Week

    IBD | Apr. 27, 2015 | 13:33PM EST
  21. Does Apple Hide More Cash Abroad Than Anyone?

    Benzinga | Apr. 26, 2015 | 13:21PM EST
  22. U.S. Tech, Dollar & Health Care ETFs To Watch This Week

    Benzinga | Apr. 26, 2015 | 10:52AM EST
  23. Cancer Drugs Impress Again

    IBD | Apr. 20, 2015 | 18:43PM EST
  24. Bristol, Merck Cancer Drugs Strut Their Stuff

    IBD | Apr. 20, 2015 | 11:29AM EST
  25. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  26. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 16:14PM EST
  27. Bristol's Opdivo Scores Again Against Lung Cancer

    IBD | Apr. 17, 2015 | 10:44AM EST
  28. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  29. UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone

    Benzinga | Apr. 14, 2015 | 13:30PM EST
  30. Robert Bruce's Top Growth Stocks

    GuruFocus | Apr. 13, 2015 | 21:36PM EST
  31. Fast Money Picks For March 2

    Benzinga | Mar. 1, 2015 | 18:54PM EST
  32. Heavy News Day For Several Biotech Stocks

    Benzinga | Feb. 25, 2015 | 15:34PM EST
  33. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  34. PRIMECAP Management's New Positions

    GuruFocus | Feb. 13, 2015 | 15:47PM EST
  35. Microsoft Does Largest Corporate Debt Sale Of Year

    IBD | Feb. 9, 2015 | 16:59PM EST
  36. Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up

    IBD | Feb. 9, 2015 | 16:53PM EST
  37. Gabelli's Q4 Picks Include Acquisition Targets

    GuruFocus | Feb. 6, 2015 | 10:44AM EST
  38. Fast Money Halftime Report Final Trade From February 5

    Benzinga | Feb. 6, 2015 | 06:45AM EST
  39. Gilead Sciences Falls 10% After More Than Doubling Drug Discounts For 2015

    GuruFocus | Feb. 5, 2015 | 11:35AM EST
  40. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  41. Merck hep C drug faces delays

    IBD | Feb. 4, 2015 | 19:29PM EST
  42. HCV Stocks Struggle As Gilead, Merck Face Headwinds

    IBD | Feb. 4, 2015 | 12:12PM EST
  43. UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline

    Benzinga | Feb. 4, 2015 | 08:03AM EST
  44. Earnings Scheduled For February 4, 2015

    Benzinga | Feb. 4, 2015 | 05:08AM EST
  45. Keep an Eye on These 10 Stocks for February 4, 2015

    Benzinga | Feb. 4, 2015 | 04:08AM EST
  46. Irving Kahn Adds to Stakes in Three Companies in Q4

    GuruFocus | Feb. 3, 2015 | 16:18PM EST
  47. What Investors Are Watching For In Regulus Therapeutics' Next Data Release

    Benzinga | Jan. 30, 2015 | 14:32PM EST
  48. Fast Money Halftime Report Final Trade From January 27

    Benzinga | Jan. 27, 2015 | 21:27PM EST
  49. White House Budget To Support Biotech Rally

    Benzinga | Jan. 27, 2015 | 16:00PM EST
  50. Putting Recent Layoff Reports in Economic Perspective

    FoxBusiness | Jan. 26, 2015 | 13:02PM EST
Trading Center